Concepedia

Philip A. Krieter

PA

Statistics

Publications

20

Citations

943

H-Index

16

Active since

1980

Affiliations

National Institutes of Health(Current)

National Institute on Drug Abuse

Covance (United States)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Jagiellonian University

Philip A. Krieter is an author at National Institutes of Health specializing in pharmacology, medicine, and pharmacokinetics.

Publications per year

1980–2019

20

Publications

20

Disposition of Posaconazole following Single-Dose Oral Administration in Healthy Subjects

Philip A. Krieter, Brian Flannery, Timothy J Musick et al. · Antimicrobial Agents and Chemotherapy · 2004 · 211 citations · Full text

, , +17

Pharmacokinetic Properties and Human Use Characteristics of an FDA‐Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose

Philip A. Krieter, Nora Chiang, Shwe Gyaw et al. · The Journal of Clinical Pharmacology · 2016 · 109 citations · Full text

, , +16

Specific inhibitors of endopeptidase 24.11 inhibit the metabolism of atrial natriuretic peptides in vitro and in vivo

Gillian M. Olins, Philip A. Krieter, Angelo J. Trapani et al. · Molecular and Cellular Endocrinology · 1989 · 72 citations

, , +2

Inhibition of Stromelysin-1 (MMP-3) by P<sub>1</sub>‘-Biphenylylethyl Carboxyalkyl Dipeptides

Craig K. Esser, Robert L. Bugianesi, Charles G. Caldwell et al. · Journal of Medicinal Chemistry · 1997 · 66 citations · Full text

, , +10

Characterization of the Antinociceptive Actions of Bicifadine in Models of Acute, Persistent, and Chronic Pain

Anthony S. Basile, Aaron Janowsky, Krystyna Gołembiowska et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 60 citations

, , +17

1–5 of 20